Since General Auger presented, we did create a medical regulatory affairs group within the Directorate of Health Services Operations. For unlicensed medications, they do track anybody who has been provided those unlicensed medications—this is since they've been put in place—and whether or not there were any reported adverse events as a result of the use of those medications.
On November 15th, 2016. See this statement in context.